Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - IMMUNE PHARMACEUTICALS INC | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - IMMUNE PHARMACEUTICALS INC | v405335_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - IMMUNE PHARMACEUTICALS INC | v405335_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - IMMUNE PHARMACEUTICALS INC | v405335_ex32-1.htm |
| EX-21.1 - EXHIBIT 21.1 - IMMUNE PHARMACEUTICALS INC | v405335_ex21-1.htm |
| EX-10.42 - EXHIBIT 10.42 - IMMUNE PHARMACEUTICALS INC | v405335_ex10-42.htm |
| EX-10.38 - EXHIBIT 10.38 - IMMUNE PHARMACEUTICALS INC | v405335_ex10-38.htm |
| EX-10.41 - EXHIBIT 10.41 - IMMUNE PHARMACEUTICALS INC | v405335_ex10-41.htm |
| 10-K - FORM 10-K - IMMUNE PHARMACEUTICALS INC | v405335_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - IMMUNE PHARMACEUTICALS INC | v405335_ex32-2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Immune Pharmaceuticals, Inc. on Form S-8 (Nos. 333-198521, 333-156438, 333-151150, 333-130865, 333-130861 and 333-130860) and Form S-3 (Nos. 333-198309 and 333-198647) of our report dated April 15, 2015, on our audits of the consolidated financial statements as of December 31, 2014 and 2013 and for each of the years in the two-year period ended December 31, 2014, which report is included in this Annual Report on Form 10-K to be filed on or about April 15, 2015.
/s/ EisnerAmper LLP
Iselin, New Jersey
April 15, 2015